Expiring federal contract
HT001426PE122 — Newcomer Supply, INC.
Department of Defense · Defense Health Agency
- Contract / PIID
- HT001426PE122
- Incumbent
- Newcomer Supply, INC.
- Incumbent UEI
- H5FNE93VLAG7
- Current end date
- June 8, 2027
- Potential total value
- $229,357
- Obligated
- $229,357
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6515 — MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Set-aside
- Not stated
- Start date
- June 9, 2026
- Place of performance
- MD
- Award type
- PURCHASE ORDER
Source: USASpending.gov award record, last checked September 8, 2026. Place of performance as reported by USASpending.
What the contract covers
THESE CUSTOM-MADE SUPPLIES INCLUDE HIGH-QUALITY CONTROL SLIDES THAT ARE USED FOR TWO PRIMARY DIAGNOSTIC FUNCTIONS: IDENTIFYING FUNGUS AND GLYCOPROTEINS IN TISSUE SECTIONS TO DIAGNOSE MORPHOLOGICALLY DIVERSE FUNGAL INFECTIONS.
Likely rebid window (estimate)
- Sources Sought / RFI: about Jun 2026 – Dec 2026 (6–12 months before the end date)
- RFP: about Feb 2027 – Apr 2027 (2–4 months before the end date)
Now inside the estimated Sources Sought / RFI window.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Defense (NAICS 325413)
- FA283522P0005 — Quidelortho Sales Company, LLC · ends December 31, 2026 · $124K
- W81K0025CA001 — Nova Biomedical Corp · ends December 31, 2026 · $336K
- FA486123C0025 — Biomerieux INC · ends January 14, 2027 · $256K
- N6817123P6017 — Abbott Laboratories, Sa · ends January 28, 2027 · $128K
- W91YTZ23C0003 — Beckman Coulter, INC · ends February 6, 2027 · $542K
- HT001426FE021 — One Lambda, INC. · ends February 9, 2027 · $847K
- HT001424P0068 — Biocare Medical LLC · ends March 24, 2027 · $225K
- W81K0024P0021 — Quidelortho Sales Company, LLC · ends March 31, 2027 · $528K
- W91YTZ24P0015 — Roche Diagnostics Corporation · ends April 14, 2027 · $379K
- N3239826P0015 — Maxim Biomedical, INC · ends May 18, 2027 · $155K